Join Spruce Health and Thomas (T.J.) Ferrante, a Partner in Foley & Lardner’s Telemedicine Industry Team and Digital Health Group, to learn more about the current regulatory landscape as it relates to digital health.
We touch on:
- The current regulatory landscape as it relates to digital health
- The key considerations when using telemedicine to prescribe controlled substances under DEA rules
- New opportunities for remote patient monitoring services
- What you can expect for the remainder of 2024
Access the recording now!
